Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Chlorhexidine Caps for Central Line Associated Blood Stream Infection Prevention in People Needing Hemodialysis: a Pilot Randomised Control Trial

NCT07019610 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT07019610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07019610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Chlorhexidine Caps for Central Line Associated Blood Stream Infection Prevention in People Needing Hemodialysis: a Pilot Randomised Control Trial
Lead sponsor
The University of Queensland
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
February 29, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catheter complications, catheter infection, catheter related complications, catheter-related infections, device related infection, device related sepsis, hemodialysis catheter infection, hemodialysis catheter-associated infection, hemodialysis complication, vascular access complication